Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. (Q54342129)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

title

Ado-trastuzumab Emtansine (T-DM1): an antibody-drug conjugate (ADC) for HER2-positive breast cancer. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

main subject

antibody

1 reference

based on heuristic

inferred from title

author name string

John M Lambert

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

Ravi V J Chari

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

language of work or name

English

0 references

publication date

10 July 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

published in

Journal of Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

volume

57

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

issue

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

page(s)

6949-6964

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

cites work

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

DOI

10.1021/JM500766W

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

PubMed publication ID

24967516

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24967516

retrieved

28 May 2018

reference URL

http://europepmc.org/abstract/MED/24967516

ResearchGate publication ID

263430254

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54342129&oldid=1647499191"